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nuclear bodies formed by polyQ-
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A mutant form of the ataxin-1 protein with an expanded polyglutamine (polyQ) tract is the underlying 
cause of the inherited neurodegenerative disease spinocerebellar ataxia 1 (SCA1). In probing the 
biophysical features of the nuclear bodies (NBs) formed by polyQ-ataxin-1, we defined ataxin-1 NBs 
as spherical liquid protein/RNA droplets capable of rapid fusion. We observed dynamic exchange of the 
ataxin-1 protein into these NBs; notably, cell exposure to a pro-oxidant stress could trigger a transition 
to slower ataxin-1 exchange, typical of a hydrogel state, which no longer showed the same dependence 
on RNA or sensitivity to 1,6-hexanediol. Furthermore, we could alter ataxin-1 exchange dynamics 
either through modulating intracellular ATP levels, RNA helicase inhibition, or siRNA-mediated 
depletion of select RNA helicases. Collectively, these findings reveal the tunable dynamics of the liquid 
RNA/protein droplets formed by polyQ-ataxin-1.
Within eukaryotic cells, complex biochemical reactions are facilitated by the concentration and restriction of 
key enzymes, substrates and regulators within well-defined membrane-bound organelles. In addition, numerous 
membrane-less intracellular compartments are important for a range of essential activities in both the cytoplasm 
(e.g. stress granules storing RNA molecules from stalled translation in response to environmental stresses1) and 
the nucleus (e.g. nucleoli functioning in the biogenesis of ribosome subunits2, Cajal bodies in the processing 
and modification of short non-coding RNAs3, or promyelocytic leukemia (PML) bodies acting as sumoylation 
factories in response to interferon and oxidative stress4). The formation of many of these membrane-less orga-
nelles is now understood to proceed via a phase separation process of specific constituent proteins, RNA and/or 
DNA molecules5. Thus, after a certain critical concentration threshold is exceeded, molecular assemblies of these 
constituents are formed with liquid-like behaviors that include fusing ability, viscous fluid dynamics, and high 
exchange rates with their surroundings in the nucleoplasm or cytoplasm6–10. This process of protein phase sepa-
ration is now viewed as an essential mechanism for efficient compartmentalization that can be rapidly responsive 
to environmental challenges or intracellular changes11,12.
Proteins that can undergo phase separation usually contain sequences conforming to either a low complexity 
region (LCR) or prion-like domain (PrLD)8,11,13; these are protein domains typically with low amino acid diver-
sity and little conformational heterogeneity5,11. These disordered structural characteristics can also contribute to 
an additional change known as protein phase transition, in which liquid-like condensates continue to become 
less dynamic and so form a more viscoelastic hydrogel or solid-like fibrous aggregates12,14. Many factors can 
promote the phase transition process such as time, pH, and altered amino acid sequences arising from gene muta-
tions8,9,15,16. Thus, sequences typically conforming to LCR or PrLD motifs have been proposed as indicators of a 
protein’s propensity to undergo protein phase separation and phase transition17,18.
In addition to this importance of membrane-less organelle formation as part of normal cellular physiology, 
many mutant proteins linked particularly to neurodegenerative diseases have also been identified with LCR or 
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Figure 1. Ataxin-1 forms concentration-dependent nuclear bodies (NBs) that are highly dynamic. 
Neuro-2a cells were transfected to express GFP-ataxin-1[85Q]. (A) At 24 h post-transfection with different 
plasmid concentrations (0.5, 1.0, or 2.0 μg/ml), cells were fixed and stained with DAPI before CLSM 
imaging. Representative images are shown from 3 independent experiments. (B) Average sizes of ataxin-1 
NBs corresponding to the conditions as per (A) were measured using CellProfiler. Results represent the 
mean ± SEM (n > 70). Significance values calculated by ANOVA, **p < 0.01, ****p < 0.0001. (C–E) At 24 h 
post-transfection, cells were incubated in an imaging chamber equilibrated with 5% CO2 at 37 °C prior to FRAP 
using CLSM. (C) Representative images are shown from 3 independent experiments with FRAP assessments 
of exchange dynamics of GFP-ataxin-1[85Q] for different size NBs (denoted as I with diameter ≤0.75 μm, II 
with diameter 0.75–2 μm, and III diameter >2 μm). White rectangles indicate the ataxin-1 NBs analyzed; white 
open arrowhead indicates photobleached area. All scale bars = 10 μm. (D) Plot of the percentage recovery of 
fluorescence from experiments as shown in (C I-III) Each symbol represents fluorescence measured at the 
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PrLD motifs. Notable examples include the liquid-like condensates and further phase transition into hydrogel by 
amyotrophic lateral sclerosis (ALS) mutants of FUS or hnRNPA19,19,20. In assessing the processes of phase separa-
tion and phase transition for other neurodegenerative diseases, it is notable that trinucleotide repeat expansions 
can be considered as a type of LCR or PrLD17,21,22. In spinocerebellar ataxia 1 (SCA1) patients, the mutant ATXN1 
gene contains CAG repeats that encode an expanded polyglutamine (polyQ) region, and the formation of distinct 
nuclear “inclusions” of these polyQ-ataxin-1 proteins in SCA1 patients and transgenic mice23–25. Initially these 
inclusions may lack the fibrillar structure typical of disease-causing amyloids22,26 but instead show highly dynamic 
exchange27. The main aim of our study is to provide the first comprehensive evaluation of the physical properties 
of these NBs, to allow us to define a relationship between NB dynamic exchange and toxicity. Here, we implement 
a suite of microscopy and biochemical approaches to define the nuclear bodies (NBs) formed by polyQ-ataxin-1 
as dynamic liquid protein/RNA droplets. These NBs exhibit ready-to-fuse ability and high dynamics revealed 
by fluorescence fluctuation spectroscopy (FFS) and fluorescence recovery after photobleaching (FRAP). More 
importantly, we have observed the tunable dynamics of these ataxin-1 NBs, with their high dynamic liquid phase 
maintained by ATP and RNA helicases, and their low dynamic hydrogel phase triggered by environmental stress. 
Thus, models that explain the protein aggregation process and pathogenesis mechanism in SCA1 neurodegener-
ation should now be extended to include polyQ-ataxin-1 protein phase separation and transition.
Results
PolyQ-ataxin-1 phase separates into liquid droplets in cells. PolyQ proteins can form larger protein 
structures that have been implicated as part of their toxicity mechanisms leading to neurodegeneration; this is 
clearly documented for the polyQ-huntingtin protein that forms heterogeneously-shaped nuclear aggregates28. 
In exploring the physical nature of the larger protein structures formed by polyQ-ataxin-1, we note that ataxin-1 
NBs have been observed in SCA1 patients29 and that GFP-ataxin-1 forms distinctive NBs within the nucleoplasm 
of different cell lines30,31. Importantly, the remarkably spherical appearance of the ataxin-1[85Q] NBs (Fig. 1A, 
upper panel) raises the possibility that these NBs arise from phase separation of the ataxin-1[85Q] protein. Phase 
separation is a phenomenon that gives rise to membrane-less liquid-like compartments that are dependent on 
protein concentration11,32, are dynamic in composition9, and that display increased coordinated movement at 
the domain boundary due to the free energy cost to leave the compartment phase33. Thus, we exploited live cell 
imaging to explore these properties of the ataxin-1 NBs.
First, we expressed GFP-ataxin-1[85Q] in Neuro-2a cells at different levels by varying the concentrations 
of the transfected expression plasmid (0.5, 1.0 and 2.0 μg/ml plasmid), noting an increase in ataxin-1 NB size 
with increased transfected plasmid (Fig. 1A,B). To examine exchange dynamics for these ataxin-1 GFP-ataxin-
1[85Q] NBs across these transfection conditions (Fig. 1C, rectangles, where I corresponds to NBs with a diameter 
≤0.75 μm, II with a 0.75–2 μm diameter, III with a >2 μm diameter), we monitored fluorescence recovery after 
photobleaching (FRAP) (Fig. 1D). A rapid recovery of fluorescence for all NBs indicated a high exchange rate 
of GFP-ataxin-1[85Q] (Fig. 1C–E). Notably, the smaller NBs (group I) showed the fastest initial recovery rates 
(Fig. 1E) achieving near complete recovery within 20 s (Fig. 1D). Fluorescence recovery was demonstrated from 
either within the NB (i.e. non-bleached NB area) or the nucleoplasm surrounding the NB (Supp Fig. 1). These 
observations support our hypothesis that ataxin-1 NBs have liquid-like properties. Furthermore, during our 
FRAP analyses we frequently observed fusion events in which the movement of GFP-ataxin-1[85Q] NBs through 
the nucleoplasm brought two spherical NBs into close proximity, followed by their rapid fusion and re-shaping 
into a single, larger spherical NB (Supp. Fig. 2 and Supp. Movie 1). This observation suggests an ataxin-1 NB 
domain boundary that spatially confines diffusion, and upon fusion with another NB, undergoes a change in 
interfacial tension that permits mixing before re-establishment of a larger phase-separated compartment.
To investigate the biophysical properties of the ataxin-1 NB domain boundary and whether it imparts coordi-
nated movement that is disrupted upon fusion with another ataxin-1 NB, we employed fluorescence fluctuation 
spectroscopy (FFS). Traditionally developed for the detection of protein oligomerisation34, a moment-based anal-
ysis of the fluctuation in fluorescence intensity recorded in each pixel of a confocal image can detect the locali-
sation of coordinated protein movement in the context of phase separation33. Thus, from rapid acquisition of a 
time series of GFP-ataxin-1[85Q] fluorescence intensity images during a NB fusion event (1000 frames, 120 ms/
frame), we calculated the ratio of the variance (2nd moment) to the mean (1st moment) of GFP-ataxin-1[85Q] 
fluorescence fluctuations recorded in each pixel of 80 frame segments (~10 s) (Fig. 2A,B). This analysis enables 
us to derive a spatial map of where GFP-ataxin-1[85Q] undergoes coordinated movement within a NB (i.e. high 
variance to mean ratio, Fig. 2C), and to trace this feature as a function of time during NB fusion (Fig. 2D).
As seen in a comparison of the fluorescent intensity images of GFP-ataxin-1[85Q] localization (top row, 
Fig. 2D) with the maps of coordinated GFP-ataxin-1[85Q] mobility (bottom row, Fig. 2D), we observed a high 
variance to mean ratio only at the NB boundaries. Then, as the two NBs become physically closer and start to fuse, 
there is a loss of coordinated GFP-ataxin-1[85Q] movement at the point of contact, which results in the high vari-
ance to mean ratio localization surrounding a single, larger spherical NB. Interestingly, upon exposure of the cells 
to an environmental pro-oxidant stress agent such as arsenite35,36, that is well-established for driving formation 
of the biomolecular condensates known as stress granules37–39, we observe a significant reduction in coordinated 
GFP-ataxin-1[85Q] mobility at the edge of the NB boundary (Fig. 2E). From quantitation of the frequency at 
indicated time for the indicated ROI. (E) Recovery initial rates (average percentage recovery of fluorescence in 
the first 15 s) (Fn%/s) were calculated and shown by the pooled data. Each symbol represents a single data point 
obtained from one ROI across 3 independent experiments. Results represent mean ± SEM (n > 7 measured 
ROIs). Significance values were calculated by ANOVA, *p < 0.05.
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which pixels are detected with a high variance to mean ratio in untreated control versus arsenite-treated cells 
(Fig. 2F) and then plotting this parameter as a function of position along a NB axis (Fig. 2G), we demonstrate 
that arsenite treatment results in a five-fold reduction in protein mobility at the NB boundary. Thus, in agreement 
with the protein concentration (Fig. 1A,B) and FRAP (Fig. 1C,D) analyses, fluorescence fluctuation spectroscopy 
(FFS) demonstrates a critical phase-separation hallmark for ataxin-1 NBs.
In addition, arsenite treatment not only decreased ataxin-1 NB dynamic exchange, but also increased 
ataxin-1[85Q] NB size (Supp. Fig. 3). Specifically, many larger ataxin-1 NBs were visible (Supp. Fig. 3A) and 
quantitative analyses demonstrated a statistically significant increase in average NB size following arsenite treat-
ment (Supp. Fig. 3B). As the total size of the population of ataxin-1[85Q] NBs per nucleus did not also signifi-
cantly increase upon arsenite exposure (Supp. Fig. 3C), these results are consistent with increased fusion of the 
ataxin-1 NBs in the presence of arsenite. To explore these relationships further, we also examined the behav-
ior of an ataxin-1[85Q] mutant with a deletion in its self-association domain (SAD)40 (amino acids 495–605, 
herein termed ataxin-1[85Q]∆SAD) (Supp. Fig. 4). In transgenic mice models, polyQ-ataxin-1[77Q]∆SAD was 
reported as toxic (also tested in Neuro-2a cells as shown in Supp. Fig. 4C), but without visible NBs41. In our cul-
tured Neuro-2a cell system, we observed that ataxin-1[85Q]∆SAD retained the ability to NBs potentially due 
to the presence of other motifs (such as CT2AXH) outside of the SAD42, but these differed from those formed 
by wild-type ataxin-1[85Q] being significantly smaller in size and not being further impacted by arsenite treat-
ment (Supp. Fig. 4). Thus, the formation of ataxin-1[85Q] NBs can be observed in the absence of the reported 
Figure 2. Fluorescence Fluctuation Spectroscopy (FFS) analysis of ataxin-1 NB fusion reveals liquid droplet-
like behavior. Neuro-2a cells were transfected to express GFP-ataxin-1[85Q] for live cell imaging. (A) A time 
series acquisition (1000 frames) of ataxin-1 NBs enables the fluctuation in GFP-ataxin-1[85Q] fluorescence 
intensity to be acquired in each pixel of an image. (B,C) Estimate of coordinated GFP-ataxin-1[85Q] mobility 
in each pixel location. (B) Calculation of the ratio of the first and second moment (variance/mean) of the 
fluorescence fluctuation recorded in each pixel, directly corresponding to the image presented in (C). (C) 
The spatial map of a low versus high ratio of the variance to the mean demonstrates coordinated GFP-ataxin-
1[85Q] mobility is at the NB boundary. (D) Time series acquisition (1000 frames) of two ataxin-1 NBs under 
control (Ctrl) conditions undergoing fusion, segmented into 10 s intervals (80 frames): the top row presents 
the intensity maps of GFP-ataxin-1[85Q] localization during each time segment and the bottom row presents 
the maps of GFP-ataxin-1[85Q] coordinated movement during each time segment. (E) Time series acquisition 
(1000 frames) of two ataxin-1 NBs not undergoing fusion in arsenite-treated cells, segmented into 10 s intervals 
(80 frames): the top row presents intensity maps of GFP-ataxin-1[85Q] localization during each time segment 
and the bottom row presents maps of GFP-ataxin-1[85Q] coordinated movement during each time segment. 
(F,G) A comparison of the degree of coordinated GFP-ataxin-1[85Q] movement (variance/mean) within (F) 
and across the axis (G) of GFP-ataxin-1[85Q] NBs undergoing fusion in Ctrl cells versus NBs not undergoing 
fusion in arsenite-treated cells. All scale bars in (C–E) = 2 μm. Images presented in (D–G) are representative 
of n = 3 cells under each condition, with average data presented in histograms in (F) and (G). Results in (G) 
represent mean ± SEM (n = 3 cells).
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self-association domain, and when integrated with the previous in vivo studies41, these results suggest that these 
smaller sized NBs may retain the potential for neurotoxicity.
In addition to evaluating the NBs formed by ataxin-1[85Q], we examined the properties of NBs formed by 
the wild-type ataxin-1[30Q] protein. Expression of GFP-ataxin-1[30Q] protein in Neuro-2a cells showed the for-
mation of spherical NBs indistinguishable morphologically from those observed for GFP-ataxin-1[85Q] (Supp. 
Fig. 5A), and consistent with previous studies43,44, thus defining higher ataxin-1 protein concentration as a major 
contributor to NB formation. Furthermore, ataxin-1[30Q] NBs showed high dynamics (Supp Fig. 5A–C) and 
fusion (Supp Fig. 5D) revealed by FRAP and live cell imaging, respectively. Taken together, these results demon-
strate ataxin-1 protein phase separation as liquid droplets with high dynamics and fusion.
RNA/transcription is required for polyQ-ataxin-1 phase separation. We next explored the depend-
ence of the formation of ataxin-1 NBs on the presence of RNA, building on previous studies demonstrating an 
interaction of ataxin-1 with RNA in vitro45 and also that RNA can contribute to protein phase separation32,46. We 
addressed this requirement for RNA/transcription in two independent protocols, and we further included an 
oxidant stress treatment by incubation of the cells in the presence of arsenite35,36. First, we assessed the impact 
of RNase-mediated degradation on ataxin-1 NBs. Pretreatment with the mild detergent saponin to permeabi-
lise cell and nuclear membranes allowed RNase A access to hydrolyse RNA. Importantly, saponin treatment 
alone did not impact the ataxin-1 NBs, and so GFP-ataxin-1[85Q] was visualized within distinct NBs (Fig. 3A, 
Figure 3. Ataxin-1 NBs are sensitive to RNase/transcription inhibition in control but not in arsenite stress 
conditions. Neuro-2a cells were transfected to express GFP-ataxin-1[85Q]. At 24 h post-transfection, cells 
were treated with arsenite as indicated (A–C), followed by treatment with (A) Saponin only (0.005%, 15 s) for 
membrane permeabilization, or Saponin + RNase A (100 μg/ml, 1 h, on ice) for RNA degradation, or (B) DMSO 
only, or Actinomycin D in DMSO (2 μg/ml, 3 h 37 °C). Cells were then fixed and stained with DAPI before 
CLSM imaging. Zoom images (right panels) correspond to the boxed regions. Representative images are shown 
from 3 independent experiments. (C) RNA synthesis was detected using imaging including the Click-iT RNA 
Alexa Fluor 594. 5-ethynyl uridine was added for 24 h before arsenite treatment, then incorporated 5-ethynyl 
uridine was detected (red). Zoom images (right panels) correspond to the boxed regions. (D) Quantitative 
analysis of RNA staining intensity ratio (NB area/non-NB area in the nucleoplasm). Each symbol represents a 
single data point. Results represent the mean ± SEM (n > 10). Significance values were calculated by unpaired 
two-tailed student’s t-test, ***p < 0.001. All scale bars = 10 μm.
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Figure 4. Different stresses can inhibit ataxin-1 NB exchange dynamics either irreversibly or reversibly. 
Neuro-2a cells were transfected to express GFP-ataxin-1[85Q]. At 24 h post-transfection, cells were left 
untreated (Ctrl) or treated with arsenite (0.3 mM, 1 h) (Arsenite) or sorbitol (0.5 M, 1 h) (Sorbitol). Following 
wash out (three washes with PBS), cells were left to recover from the stress treatment for 3 h (Arsenite wash out 
or Sorbitol wash out). (A) Representative images are shown from 3 independent experiments for quantitative 
assessments of GFP-ataxin-1[85Q] exchange dynamics. White rectangle indicates ataxin-1 NB imaged 
analyzed. A small ROI (indicated by white open arrowhead for dynamic NB or white solid arrowhead for non-
dynamic NB) was photobleached and the fluorescence recovery was subsequently monitored as post-bleach 
at 5 s intervals for 250 s. (B) Plot of the percentage recovery of fluorescence from experiments as shown in 
(A). Each symbol represents fluorescence measured at the indicated time. (C,D) Results for pooled data for 
FRAP experiments. The recovery of fluorescence for GFP-ataxin-1[85Q] over time was analyzed. Each symbol 
represents a single data point. Results represent the mean ± SEM for (C) fluorescence maximum recovery 
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upper two rows). In contrast, saponin followed by RNase A treatment resulted in a diffuse nuclear distribution of 
GFP-ataxin-1[85Q] for control cells; however, for cells previously treated with arsenite, we noted that the ataxin-1 
NBs remained following RNase A treatment (Fig. 3A). We next considered the impact of the transcriptional 
inhibitor actinomycin D47. In control cells treated with actinomycin D for 3 h, we again noted a diffuse distribu-
tion of GFP-ataxin-1[85Q] in the nucleus; but for cells pre-treated with arsenite for 1 h, followed by washout and 
actinomycin D treatment for 3 h, we continued to observe distinct ataxin-1 NBs (Fig. 3B). We further examined 
ataxin-1 NBs for the presence of newly-synthesized RNA48. We noted intense staining for RNA throughout the 
nucleus; this included regions occupied by the GFP-ataxin-1[85Q] nuclear bodies, albeit at levels lower than in 
the surrounding nucleoplasm; under arsenite-treated conditions, we continued to detect RNA throughout the 
nucleus, without distinctive accumulation within ataxin-1 NBs (Fig. 3C). Indeed, quantitative analysis showed 
that arsenite treatment resulted in lower RNA levels in areas corresponding to the ataxin-1 NBs (Fig. 3D). These 
observations support a model in which low RNA levels are critical in initiating liquid droplet formation whereas 
higher RNA levels trigger droplet disassembly49,50. Thus, ataxin-1 NBs are less reliant on RNA levels when in the 
presence of arsenite stress.
Different forms of stresses trigger phase transition of liquid ataxin-1 NBs to a reversible or 
an irreversible hydrogel. The liquid droplets formed by proteins with low complexity region (LCR) or 
prion-like domain (PrLD) motifs can show a time-dependent transition through an aging/maturation process20,51. 
Furthermore, exposure of cells to a range of environmental stress agents, such as arsenite, can enhance stress 
granule formation37–39. Therefore, we next assessed the impact of arsenite on the maturation/phase transition of 
ataxin-1 NBs. Our FRAP analyses revealed a significant slowing of GFP-ataxin-1[85Q] maximum recovery and 
initial rate of recovery, an impact not reversed upon arsenite washout (Fig. 4).
We extended our interrogations to include a second environmental insult in the form of hyperosmotic stress 
induced by addition to the cell culture medium of the non-metabolisable sugar, sorbitol; this change in osmo-
larity can also promote the formation of cytoplasmic stress granules52,53. We again observed significant slowing 
of GFP-ataxin-1[85Q] maximum recovery and initial rate of recovery, but these changes could be reversed upon 
the return of the cells to normal osmotic conditions (Fig. 4). Thus, the impact of stress on the transition to form 
non-dynamic ataxin-1 NBs is dependent on the nature of the initiating stress. This altered physical state of the 
ataxin-1 NBs does not appear to be caused by altered levels of ataxin-1 expression under these stress conditions, 
with no significant differences in total fluorescence intensity observed across the control, arsenite, or sorbitol 
treatments (Supp. Fig. 6). To further test the state of the ataxin-1 NBs under different conditions, 1,6-hexanediol, 
a chemical probe to differentiate liquid-like assemblies from solid-like assemblies8,54, was added to the cells 
expressing GFP-ataxin-1[85Q] under control or stress conditions (arsenite or sorbitol). Whilst ataxin-1 NBs 
exhibit a liquid-like state sensitive to 1,6-hexanediol, NBs pre-treated with stress (arsenite but not sorbitol) exhibit 
a solid-like state as they are 1,6-hexanediol resistant (Fig. 5). Thus, ataxin-1 protein exchange and the properties 
of ataxin-1 NBs are rapidly responsive to environmental changes.
Maintenance of the ataxin-1 NB liquid phase requires ATP. The maintenance of liquid droplet high 
dynamics, for membrane-less organelles such as nucleoli, is ATP-dependent7. Therefore, we next addressed the 
ATP requirement in the dynamic exchange of GFP-ataxin-1[85Q] in ataxin-1 NBs. We lowered ATP levels with 
2-Deoxy-D-glucose (2DG) and Carbonyl cyanide m-chlorophenyl hydrazone (CCCP)55,56 and confirmed ATP 
recovery upon inhibitor washout (Supp. Fig. 7). Strikingly, maximum and initial rates of fluorescence recovery 
were significantly and irreversibly inhibited by ATP depletion (Fig. 6A–D), indicating the irreversibility of the 
phase transition process following ATP depletion.
Down regulation of DEAD/H-box RNA helicases decreases ataxin-1 NB dynamic exchange. 
Whilst ATP can directly influence the phase transition process57,58, intracellular ATP levels are also critical for 
the actions of multiple ATP-dependent enzymes and chaperones59,60. We previously identified 13 RNA helicases 
in the ataxin-1 interactome (see ProteomeXchange, PXD010352)61. RNA helicases have ubiquitous roles in reg-
ulating RNA structures as well as RNA-RNA and RNA-protein interactions in multiple different aspects of RNA 
metabolism, including transcription, mRNA splicing, RNA export, translation and RNA degradation62,63. The two 
largest groups within the RNA helicase family are the DEAD-box (DDX) and DEAH-box (DHX) helicases63. That 
these RNA helicases may contribute to protein phase transition of membrane-less NBs is seen with siRNA-driven 
decrease in RNA helicase CGH-1/DDX6 levels resulting in non-dynamic ribonucleoprotein (RNP) granules64.
We initially showed that RK-33, an inhibitor that binds the ATP-binding cleft of RNA helicase(s)65,66, could 
decrease the exchange dynamics of ataxin-1 NBs (Fig. 7). We next incubated cells in the presence of siRNAs tar-
geting each of the 13 RNA helicases of the ataxin-1 interactome. Our initial FRAP assessments directed our focus 
to siRNA targeting of the helicases DDX21, DDX19A, DDX42, DDX46, and DHX15. We ensured that the levels 
of each, as assessed by Western blot, were decreased by siRNA treatment (Supp. Fig. 8). Using FRAP protocols, we 
assessed how these helicase-targeted siRNA treatments, alongside control siRNA treatment, altered the dynam-
ics of recovery. Our quantitative analysis of the pooled data confirmed that DDX42, DDX46, or DDX15 siRNA 
significantly decreased the dynamic exchange of the ataxin-1 NBs (Fig. 8) by decreasing both the maximum 
percentage in the bleached area (where 100% represents full recovery) and (D) the initial rate of fluorescence 
recovery percentage in the bleached area for first three time points (0–15 s of post-bleach). Significance 
values were calculated by (C) ANOVA or (D) Mann-Whitney and Kruskal-Wallis non-parametric test, n > 7, 
****p < 0.0001, ###p < 0.001, n.s. = not significant. All scale bars = 10 μm.
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fluorescence recovery (Fig. 8C) and the initial recovery rate (Fig. 8D). When we assessed the intracellular locali-
zation of each helicase, we further noted that DDX42, DDX46, and DHX15 were more nuclear than cytoplasmic 
(Supp. Fig. 9A,B). Taken together, these results reinforce the observation that DDX42, DDX46 and DHX15 are 
predominantly nuclear RNA helicases that contribute to the regulation of the dynamic exchange of ataxin-1 NBs.
The processes of protein phase transition have been previously discussed as part of a time-dependent or 
“aging” process that can be linked to neurodegeneration. For example, in ALS, protein condensates formed by 
FUS or hnRNPA1 can transit to a more solid hydrogel or aggregate phase8,9,19. Initially this process can be reversed 
by ATP-dependent chaperones or disaggregases67, but the increasing spatial order of these protein assemblies 
then promotes a transition to a solid-like fibrous aggregate, that may be toxic for neurons and so be a driver of 
ALS neurodegeneration14. We therefore tested the impact of down regulation of RNA helicases on cell viability as 
an approach to defining whether RNA helicase sequestration/disruption might underpin ataxin-1[85Q]-driven 
cell toxicity. Treatment of the cells with siRNAs directed to the helicases DDX42, DDX46, or DHX15 that decrease 
ataxin-1 NBs dynamics (Fig. 8) did not significantly increase cell death percentage in GFP-expressing cells, and 
indeed there was a small but significant increase in viability noted for the DDX42 siRNA-treated GFP-expressing 
cells (Supp Fig. 10). This demonstrates that a disruption of RNA helicases, and in particular the single disruption 
of DDX42, DDX46 or DHX15, is not a toxic event per se, but it also further suggests a decreased dynamics of 
ataxin-1[85Q] NBs that is observed upon the down regulation of specific RNA helicases is not caused by reduced 
cell viability.
Arsenite increases ataxin-1[85Q]S776A toxicity and decreases ataxin-1[85Q]S776A NB 
dynamic exchange. To further explore any correlation between NB size and dynamics and cell toxicity, 
an ataxin-1 S776A mutant (ataxin-1 serine 776 mutated to the non-phosphorylatable alanine)68,69 was examined 
(Fig. 9). Indeed, ataxin-1[85Q]S776A remained non-toxic under control conditions as reported68,69 with levels of 
cell death being not statistically different from those recorded for GFP-only transfected cells (Fig. 9A). However, 
upon arsenite treatment, we observed statistically significant increases in death of cells expressing GFP-only, 
GFP-ataxin-1[85Q] or GFP-ataxin-1[85Q]S776A such that toxicity for cells expressing either form of ataxin-1 
was comparable (Fig. 9A). When we examined the morphology of ataxin-1 protein exchange for the NBs formed, 
we observed that ataxin-1[85Q]S776A formed smaller NBs that did not increase in size upon arsenite treatment 
(Fig. 9B). This suggests that size of the formed NB cannot itself be used as a predictor of toxicity, and thus we 
further considered the dynamics of these NBs, noting the similar level of high dynamics of ataxin-1 exchange 
for both the ataxin-1[85Q] and ataxin-1[85Q]S776A NBs, and with the dynamic exchange of both significantly 
slowing upon arsenite exposure (Fig. 9E–G). These results suggest that decreased NBs dynamics may be related 
to enhanced cytotoxicity, but this interpretation may be complicated by the broad spectrum of impacts of arsenite 
exposure35–39.
Discussion
Proteins with LCR or PrLD have attracted much recent attention due to their ability to phase separate to liquid 
droplets and transition to disease-associated non-dynamic aggregates8,9,19. Here we interrogate polyQ-ataxin-1 
NBs in cells to show, for the first time, their multiple liquid-like properties and phase transition to structures 
with lower dynamic exchange. Based on our findings of NB fusion and the altered protein exchange dynamics 
we propose a model, as depicted in Fig. 10, in which the ataxin-1 protein undergoes phase separation and then 
Figure 5. Liquid-like or solid-like properties of ataxin-1 NBs under control or stress conditions. Neuro-2a 
cells were transfected to express GFP-ataxin-1[85Q]. At 24 h post-transfection, cells were left untreated (Ctrl) 
or treated with arsenite (0.3 mM, 1 h) (Arsenite) or sorbitol (0.5 M, 1 h) (Sorbitol). Cells were further treated 
with 1,6-hexanediol (5%, 5 min) to discriminate between liquid-like assemblies and solid-like assemblies. Cells 
were then fixed and stained with DAPI before CLSM imaging. Each symbol represents a single data point. 
Representative images are shown from 3 independent experiments. All scale bars = 10 μm.
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transitions via the liquid droplet state to ultimately form a less dynamic state typical of a hydrogel. In the following 
paragraphs, we discuss key features of this model and its integration with the current concepts of the formation of 
biomolecular condensates and the reported physical features and toxicity of polyQ proteins.
Initially, the formation of NBs is favoured by an increased concentration of the ataxin-1 protein itself 
(Fig. 1). Whilst proteins at low concentrations show diffuse intracellular distributions, phase separation 
can be observed when a critical threshold concentration intrinsic to each protein is exceeded8,11–13,19. This 
concentration-dependent phase separation has been reported for multiple LCR/PrLD-containing proteins, 
including ALS disease-causing proteins FUS, hnRNPA1, TIA1, and polyQ protein WHI312; because the polyQ 
tract is a predicted PrLD21,22, polyQ-ataxin-1 is expected to behave in this way in cells. Consistent with previous 
reports70, here we have shown that both mutant polyQ-ataxin-1 (with an expanded polyQ tract) and wild-type 
ataxin-1 protein (with a shorter polyQ tract) can form NBs (Fig. 1 and Supp. Fig. 3). Importantly, although the 
toxic form of ataxin-1 was first identified with an expanded polyQ tract23,71, increased expression of even the 
wild-type ataxin-1 causes SCA1 phenotypic changes in flies and mice models43,44. Thus, increased ataxin-1 protein 
levels are important in the toxicity mechanisms in SCA1 and a significant consequence of an expanded polyQ 
Figure 6. Dynamic ataxin-1 NBs transit to irreversible non-dynamic hydrogel following intracellular ATP 
depletion. Neuro-2a cells were transfected to express GFP-ataxin-1[85Q]. At 24 h post-transfection, cells were 
left untreated (Ctrl) or treated with 2DG + CCCP (ATP depletion). Inhibitors were washed out (3 washes 
with PBS) and cells were left to recover for 3 h (ATP recovery). (A) Representative images are shown from 
3 independent experiments for quantitative assessments of GFP-ataxin-1[85Q] exchange dynamics. White 
rectangle indicates ataxin-1 NB analyzed. A small ROI (indicated by white open arrowhead for dynamic 
NB or white solid arrowhead for non-dynamic NB) was photobleached and the fluorescence recovery 
was subsequently monitored as post-bleach at 5 s intervals for 250 s. (B) Plot of the percentage recovery of 
fluorescence from experiments as shown in (A). Each symbol represents fluorescence measured at the indicated 
time. (C,D) Results for pooled data for FRAP experiments. The recovery of fluorescence for GFP-ataxin-1[85Q] 
over time was analyzed. Each symbol represents a single data point. Results represent the mean ± SEM for (C) 
fluorescence maximum recovery percentage in the bleached area (where 100% represents full recovery) and (D) 
the initial rate of fluorescence recovery percentage in the bleached area for first three time points (0–15 s of post-
bleach). Significance values were calculated by Mann-Whitney and Kruskal-Wallis non-parametric test, n > 7, 
##p < 0.01, ####p < 0.0001, n.s. = not significant. All scale bars = 10 μm.
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tract is increased stability that favours the accumulation of higher levels of ataxin-172 and thus the formation of 
ataxin-1 NBs.
RNA also contributes to the processes of phase separation for ataxin-1 as demonstrated by our results showing 
the impact of RNase treatment or actinomycin D exposure to drive diffuse distribution of the ataxin-1 protein 
mainly in the nucleus (Fig. 3). Whilst RNA alone can undergo phase separation into liquid droplets10, RNA 
can also change the material properties of protein assemblies to influence phase separation and transition12,32,73. 
Ataxin-1’s ability to interact with RNA in vitro has been reported as showing strong binding to poly(rG) but 
weaker binding to poly(rU), poly(rA), and poly (rC)45. Our bioinformatics assessment of the ataxin-1 interac-
tome61 highlights a link of ataxin-1 to the processes of RNA metabolism and specifically identified multiple RNA 
helicases. Our identification of the RNA helicases DDX42, DDX46, and DHX15 which function in pre-mRNA 
processing74–76 as regulators of ataxin-1 NBs dynamics (Figs. 7 and 8) reinforces a functional association of 
ataxin-1 with RNA metabolism68,77.
We also characterized the liquid droplet state of the ataxin-1 NBs (Figs. 1 and 2). Importantly, our FFS analy-
ses revealed that the ataxin-1 NB boundary imparts coordinated movement and that upon fusion of two individ-
ual ataxin-1 NBs the interfacial tension established by this boundary is disrupted such that mixing between the 
two compartments is permitted and a single larger NB is formed. The application of FFS to quantify molecular 
Figure 7. RNA helicase inhibitor RK-33 slows ataxin-1 NB exchange dynamics. Neuro-2a cells were transfected 
to express GFP-ataxin-1[85Q]. At 4 h post-transfection, cells were left untreated (Ctrl) or treated with RK-33 (20 
μM or 40 μM) for 24 h. (A) Representative images are shown from 3 independent experiments for quantitative 
assessments of GFP-ataxin-1[85Q] exchange dynamics. White rectangle indicates ataxin-1 NB analyzed. A 
small ROI (indicated by white open arrowhead for dynamic NB or white solid arrowhead for non-dynamic NB) 
was photobleached and the fluorescence recovery was subsequently monitored as post-bleach at 5 s intervals 
for 250 s. (B) Plot of the percentage recovery of fluorescence from experiments as shown in (A). Each symbol 
represents fluorescence measured at the indicated time. (C,D) Results for pooled data for FRAP experiments. 
The recovery of fluorescence for GFP-ataxin-1[85Q] over time was analyzed. Each symbol represents a 
single data point. Results represent the mean ± SEM for (C) fluorescence maximum recovery percentage 
in the bleached area (where 100% represents full recovery) and (D) the initial rate of fluorescence recovery 
percentage in the bleached area for first three time points (0–15 s of post-bleach). Significance values were 
calculated by Mann-Whitney and Kruskal-Wallis non-parametric test, n > 10, #p < 0.05, ##p < 0.01, ###p < 0.001, 
####p < 0.0001. All scale bars = 10 μm.
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Figure 8. ATP-dependent RNA helicases DDX42, DDX46 and DHX15 are required for ataxin-1 NB rapid 
exchange dynamics. Neuro-2a cells were co-transfected with plasmid encoding GFP-ataxin-1[85Q] and siRNAs: 
negative siRNA ctrl, DDX21, DDX19A, DDX42, DDX46, or DHX15, as indicated. At 24 h post-transfection, 
cells were incubated in an imaging chamber equilibrated with 5% CO2 at 37 °C prior to FRAP using CLSM. 
(A) Representative images are shown from 4 independent experiments for quantitative assessments of GFP-
ataxin-1[85Q] exchange dynamics under different siRNA conditions. White rectangle indicates ataxin-1 NB 
analyzed. A small ROI (indicated by white open arrowhead for dynamic NB or white solid arrowhead for non-
dynamic NB) was photobleached and the fluorescence recovery was subsequently monitored as post-bleach 
at 5 s intervals for 250 s. (B) Plot of the percentage recovery of fluorescence from experiments as shown in 
(A). Each symbol represents fluorescence measured at the indicated time. (C,D) Results for pooled data for 
FRAP experiments. The recovery of fluorescence for GFP-ataxin-1[85Q] over time was analyzed. Each symbol 
represents a single data point. Results represent the mean ± SEM for (C) fluorescence maximum recovery 
1 2Scientific RepoRtS |         (2020) 10:1557  | https://doi.org/10.1038/s41598-020-57994-9
www.nature.com/scientificreportswww.nature.com/scientificreports/
mobility within intracellular compartments has contributed important new insights into accessibility of nuclear 
structures and the properties of biomolecular condensates, including the heterochromatin domain formed by 
phase separation33,78,79. By capitalizing on the capacity of FFS to detect the localisation of coordinated protein 
movement, we recover a map that reports the coordinated movement of ataxin-1 in and out of the NB, which can 
be tracked as a function of time and modified by arsenite stress (Fig. 2). Thus, FFS should be considered a critical 
inclusion in the approaches to study biomolecular condensates.
Importantly, our use of FRAP protocols revealed the tunable dynamics of ataxin-1 exchange for these NBs; 
exchange under control conditions was rapid, but multiple factors could slow this exchange. This reinforces the 
concepts of phase transition in which liquid-like condensates show rapid fusion and high dynamics, but then the 
processes of phase transition result in the formation of non-dynamic hydrogels, and ultimately solid-like fibrous 
aggregates, characterized by a higher spatial order of protein structures and decreased exchange dynamics with 
their environment14. For ataxin-1 NBs, we showed that this characteristic of the phase transition process could 
be promoted by the exposure of the cells to different forms of environmental stress (Figs. 4 and 5) or ATP deple-
tion (Fig. 6). These changes echo the observations of previous studies that highlighted a maturation of dynamic 
ataxin-1 NBs over time to result in mixed populations with slow- or fast-exchanging components70, and support 
the notion that external factors such as temperature, pH, salinity, oxidative stress or osmolarity can promote 
phase separation and transition12,80. The application of arsenite or sorbitol stress is known to induce the formation 
of the biomolecular condensates known as stress granules37–39,52,53 by causing pro-oxidative or hyperosmotic stress 
responses, respectively, that ultimately stall protein translation37,53. Here we have noted a striking difference for 
ataxin-1 NBs: the transition to the non-dynamic hydrogel state is irreversible if initiated by arsenite, but reversi-
ble if initiated by osmotic stress. The exact mechanisms underlying these differences require further evaluation, 
but may reflect irreversible oxidative damage in the presence of arsenite, but reversible osmotic control via water 
efflux and influx81 when osmolarity is modulated by the presence of different concentrations of sorbitol.
Our study has provided the first comprehensive evaluation of the physical properties of these NBs (Figs. 1–6), 
evaluating a suite of manipulations that allow us to define a relationship between NB dynamic exchange and tox-
icity (Figs. 7, 8, Supp. Figs. 9 and 10). Thus, we propose that possible links between the regulation of ataxin-1 NB 
dynamics and the neurodegeneration observed in SCA1 patients should be an important area for future investiga-
tion. A dynamic exchange in the liquid droplet stage of the ataxin-1 NB formation would not restrict the transport 
of associated proteins into and/or exiting the NB27; thus ataxin-1 NBs are disassembled during mitosis and then 
ataxin-1 protein can be re-distributed into two cells82. With the phase transition to an irreversible hydrogel as that 
caused by ATP depletion or arsenite stress, it is inevitable that cellular function would be impacted if additional 
proteins essential for normal cellular functions are sequestered. Current SCA1 murine models (e.g. SCA1[82Q] 
transgenic mice83–85 or SCA1[154Q/2Q] knock-in mice86–88) rely on the assessment of downstream pathological 
impacts but, to date, have not included fluorescent protein tagging of the expressed polyQ-ataxin-1 protein. Thus, 
future studies in murine SCA1 models engineered to express fluorescent protein-tagged polyQ-ataxin-1 will ena-
ble the study of the dynamics of ataxin-1 NBs in Purkinje cells, for example by capitalizing on recent advances in 
lattice light sheet microscopy that offer advantages in spatial and temporal resolution as well as low phototoxic-
ity89,90. The polyQ-ataxin-1 phase transition model that we propose (Fig. 10) will thus provide a framework for 
ongoing investigations to contribute new knowledge to a mechanistic understanding how polyQ-ataxin-1 can 
drive the pathological changes observed in the neurodegenerative disease SCA1.
Materials and Methods
Cell culture, transfection and treatments. Mouse neuroblastoma cells (Neuro-2a) were used in a 
majority of experiments and were cultured in growth medium: Opti-MEM (Gibco) supplemented with 2 mM 
L-glutamine (Gibco), 10% (v/v) fetal bovine serum (BOVOGEN) and 100 U/ml penicillin/streptomycin (Gibco). 
Where indicated in control experiments, Ad293 cells were cultured in Dulbecco’s Modified Eagle’s media 
(DMEM) supplemented with 10% [v/v] fetal bovine serum (FBS) (BOVOGEN) and 100 U/ml penicillin/strep-
tomycin (Gibco). Cells were plated and cultured (16 h) for the following protocols: immunofluorescence and 
RNA staining (12-well plate, Corning), Western blot (6-well plate, Corning), live cell imaging (8-well μ-slides, 
Ibidi), and ATP measurements (96 well plate, Corning) then, transfected with the indicated GFP-ataxin-1[85Q] 
or GFP-ataxin-1[30Q] constructs using Lipofectamine 2000 reagent (Invitrogen) according to the manufacturer’s 
instructions (24 h). Unless indicated otherwise, 1 µg plasmid DNA/mL culture medium was used per transfection.
Cells transfected to express GFP-ataxin-1 proteins were subjected to different treatments as follows. For envi-
ronmental stress, cells were exposed to either the pro-oxidant stress of arsenite (0.3 mM, 1 h, 37 °C) (Sigma), 
whereas for hyperosmotic stress cells were exposed to the non-metabolisable sugar D-sorbitol (0.5 M, 1 h, 37 °C) 
(Ajax Finechem). For RNase treatment, cells were treated with saponin (0.005%, 15 s, room temperature) (Sigma) 
prior to the addition of RNase A (100 μg/ml, 1 h, ice) (Invitrogen); thus, saponin-only treatment was employed 
in parallel control studies. For transcription inhibition, cells were exposed to actinomycin D (2 μg/ml, 3 h, 37 °C) 
(Sigma), with an equivalent exposure to only the vehicle DMSO (0.2%, 3 h, 37 °C) (Merck), as a negative control. 
For 1,6-hexanediol treatment, cells were incubated with 5% 1,6-hexanediol (5 min, RT) (Sigma) prior to cell 
fixation. For RK-33 treatment, cells were treated with 20 μM or 40 μM RK-33 (Adooq, A16194) (24 h, 37 °C) 4 h 
percentage in the bleached area (where 100% represents full recovery) and (D) the initial rate of fluorescence 
recovery percentage in the bleached area for first three time points (0–15 s of post-bleach). Significance values 
were calculated by ANOVA, n > 10, *p < 0.05, **p < 0.01, **** p < 0.0001, n.s. = not significant. All scale 
bars = 6 μm.
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Figure 9. Non-toxic ataxin-1 mutant S776A shows increased toxicity and decreased NB exchange dynamics 
similar to ataxin-1[85Q] level following arsenite stress. Neuro-2a cells were transfected with GFP, GFP-ataxin-
1[85Q], or GFP-ataxin-1[85Q]S776A as indicated. At 24 h post-transfection, cells were left untreated or treated 
with arsenite (0.3 mM, 1 h). (A) Cell death percentage for the transfected cell population was assessed by 
staining with the SYTOX Red dead cell stain followed by flow cytometry analysis. (B,C) Cells were fixed and 
stained with DAPI before CLSM imaging. Representative images are shown from 3 independent experiments. 
(C) Average sizes of ataxin-1 NBs corresponding to the conditions as per (B) were measured using CellProfiler. 
Results represent the mean ± SEM (Significance values calculated by ANOVA, n > 70, ****p < 0.0001, 
n.s. = not significant). (D–G). cClls were incubated in an imaging chamber equilibrated with 5% CO2 at 
37 °C prior to FRAP using CLSM. (D) Representative images are shown from 3 independent experiments 
for quantitative assessments of GFP-ataxin-1[85Q] or S776A exchange dynamics. A small ROI (indicated 
by white open arrowhead for dynamic NB or white solid arrowhead for non-dynamic NB; S776A ROI with 
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after transfection. For ATP depletion, cells were exposed to 2-deoxyglucose (2DG) (20 mM, 1 h, 37 °C) (Adrich 
Chem), + Carbonyl cyanide m-chlorophenyl hydrazine (CCCP) (100 μM, 1 h, 37 °C) (Sigma).
Immunostaining. Neuro-2a cells were cultured on coverslips (Proscitech) within 12-well plates, transfected 
and treated with 0.3 mM arsenite, as indicated. Subsequent processing was performed in phosphate-buffered 
saline at room temperature as follows: washing, permeabilization (0.2% (v/v) Triton X-100), fixation (4% (w/v) 
paraformaldehyde) and blocking (1% (w/v) bovine serum albumin (BSA)). Cells were incubated sequen-
tially with primary antibodies then fluorophore-conjugated secondary antibodies as indicated, each in 1% 
(w/v) BSA in phosphate-buffered saline (PBS) for 1 h at room temperature: anti-DDX19A (Abcam, ab108462) 
(1:100), anti-DDX21 (Atlas antibodies, 10528-1-AP) (1:100), anti-DDX42 (Proteintech, HPA023571) (1:100), 
anti-DDX46 (Atlas antibodies, 16927-1-AP) (1:100), anti-DHX15 (Proteintech, HPA047047) (1:100). Subsequent 
detection used Alexa Fluor® 568-conjugated secondary antibodies (A-11004, Invitrogen) (1:400). Nuclei were vis-
ualized using 4’,6-diamidino-2-phenylindole (DAPI) (Sigma) (1:10,000 in PBS). Processed coverslips were then 
mounted in water-based Fluoro-Gel (Proscitech) onto glass slides for visualization.
RNA staining. For detection of RNA the Click-iT RNA Alexa Fluor 594 imaging kit (ThermoFisher, C10330) 
was used. Cells were co-incubated with 5-ethynyl uridine during the transfection. After 24 h, cells were fixed and 
washed; incorporated 5-ethynyl uridine was detected according to the manufacturer’s instructions.
Confocal laser scanning microscopy (CLSM) and image analysis. Fixed samples were visualized by 
confocal laser scanning microscopy (CLSM) (Leica TCS SP5 with 63X 1.4 Oil Objective). All imaging studies 
were performed on >3 independent occasions including preliminary optimization steps. The acquired images 
were quantitatively analyzed using CellProfiler cell image analysis software (version 2.1.1 for Mac) for ataxin-1 
NB size (μm2; the size of individual NBs as well as the total size of NBs per nucleus calculated by summing the 
size of all individual NBs within a nucleus) and the fluorescence intensity of nucleus/cytoplasm ratio (Fn/c) 
for localization of RNA helicases. In the Fn/c analyses, after applying the “CorrectIllumination” function, cyto-
plasmic areas were defined by subtracting the area stained with DAPI. Where indicated, acquired images were 
quantitatively analyzed using Fiji for fluorescence intensity of RNA staining within NBs/non-NBs or total nuclear 
fluorescence intensity (pixels). Quantitation of the RNA fluorescence ratio of NB/non-NB was calculated using 
the formula: (FNB − Fbackground)/(Fnon-NB − Fbackground), in which FNB represents average RNA fluorescence intensity 
in the NB area, Fnon-NB represents average RNA fluorescence intensity in the non-NB area in the nucleoplasm and 
FBackground represents average RNA fluorescence intensity in the background of the image.
Live cell imaging, fluorescence recovery after photobleaching (FRAP) and fluorescence 
fluctuation spectroscopy (FFS). At 24 h post-transfection, culture medium was replaced with pre-warmed 
Phenol-Red-Free DMEM growth medium (Gibco). Cells were kept in an environmental chamber (37 °C, 5% 
CO2) throughout live cell imaging, as well as the FRAP and FFS acquisitions. Image stacks acquired during 
GFP-ataxin-1 NB fusion events or FRAP analysis were collected using the CLSM Leica TCS SP5 (63X 1.4 Oil 
Objective). Images stacks acquired during GFP-ataxin-1 NB fusion events and subsequent fluorescence fluctua-
tion analysis were collected using the Zeiss Elyra 780 (63X 1.2 Water Objective).
For FRAP, GFP was excited with the 488 nm emission line of an Argon laser with maximum laser power (50% 
for Leica TCS SP5) lasting one frame used for photobleaching. Three frames were recorded before photobleaching 
at a minimal interval (1.3 s). Fluorescence recovery was recorded at 5 s intervals for 250 s. Fluorescence inten-
sity was measured using Fiji. Recovery curve fitting and maximum fluorescence recovery were calculated in 
SigmaPlot 12.0. Initial rate was calculated as the average fluorescence recovery rate for the first 15 s.
For FFS, 1000 frames (64 × 64 pixel) were acquired using a digital zoom of 10 (13.5 μm region of interest) and 
a 12.61 μs pixel dwell time which resulted in a line time of 1.89 ms and frame time of 121 ms. GFP was excited 
with the 488 nm emission line of an Argon laser and detected using the 510–560 nm emission range. The average 
and variance were calculated in each pixel of every 80 frames (approximately every 10 s per segment) within the 
1000 frame acquisition using the Number and Brightness algorithms as executed by the SimFCS software devel-
oped at the University of California Irvine Laboratory for Fluorescence Dynamics (www.lfd.uci.edu).
ATP measurement. Cellular ATP levels were measured using a luminescent ATP detection assay kit 
(Abcam, ab113849) according to the manufacturer’s instructions.
multiple small NBs was indicated also by the white circle) was photobleached and the fluorescence recovery was 
subsequently monitored as post-bleach at 5 s intervals for 250 s. Scale bars = 10 μm. (E) Plot of the percentage 
recovery of fluorescence from experiments as shown in (D). Each symbol represents fluorescence measured at 
the indicated time. (D–E) Pooled data from FRAP experiments measuring recovery of fluorescence for GFP-
ataxin-1[85Q] or GFP-ataxin-1[85Q] S776A over time. Each symbol represents a single data point. The results 
are also represented as the mean ± SEM for (F) fluorescence maximum recovery percentage in the bleached area 
(where 100% represents full recovery) and (F) initial rates (average percentage recovery of fluorescence in the 
first 15 s) (Fn%/s). Significance were values calculated by ANOVA, n > 7, ***p < 0.0001, ****p < 0.001, n.s. = not 
significant.
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Gene knockdown by siRNA. ON-TARGETplus SMARTpool siRNAs were purchased from Dharmacon: 
D1Pas1(L-059783-01-0005), DDX1(E-052098-00-0005), DDX18(L-063435-01-0005), DDX19A(L-045066-01-0005), 
DDX21(L-046395-01-0005), DDX24(L-042299-01-0005), DDX3Y(L-043317-01-0005), DDX41(L-052130-00-0005), 
DDX42(L-054910-01-0005), DDX46(L-066260-01-0005), DHX15(L-044833-01-0005), DHX9(L-056729-02-0005), 
UPF1(L-050929-01-0005). Each siRNA was co-transfected with GFP-ataxin-1[85Q] using DharmaFECT Duo 
Transfection Reagent (T-2010-03). Efficacy of knockdown by each siRNA was assessed by cell lysis and Western blot as 
described in the following section.
Cell lysis and western blot. Cell lysates were prepared in RIPA buffer [50 mM Tris-HCl, pH 7.3, 150 mM 
NaCl, 0.1 mM ethylenediaminetetraacetic acid (EDTA), 1% (v/v) sodium deoxycholate, 1% (v/v) Triton X-100, 
0.2% (w/v) NaF and 100 µM Na3VO4] supplemented with Complete protease inhibitor mix (Roche Diagnostic). 
Cell lysates were incubated on ice (20 min), cleared by centrifugation, and protein concentrations determined 
using the BioRad protein assay.
Protein samples were separated by SDS-PAGE (8% polyacrylamide gels, 1.5 h) and transferred to polyvi-
nylidene difluoride (PVDF) membranes (Amersham Life Science; 2 h, room temperature). Subsequent steps were 
performed by blocking with 1% (w/v) BSA in phosphate-buffered saline (PBS; 0.5 h, room temperature), and 
incubating with primary antibodies (all anti-DDX antibodies as per those used in immunofluorescence analy-
ses) and horseradish peroxidase-linked secondary antibodies (ThermoFisher Scientific) (1:1000) for visualization 
using an enhanced chemiluminescence detection system (ThermoFisher Scientific). Images were captured using 
ChemiDoc imager (Bio-Rad) operating in a single-channel protocol.
Cell death assessment. Neuro-2a cells (2 × 105 cells/well) with transfection as indicated in different con-
ditions, were suspended in PBS and transferred to 5 ml glass round-bottom tubes (BD Bioscience). To determine 
the numbers of dead cells per sample, the SYTOX Red dead cell stain (ThermoFisher Scientific) was added to 
cell suspensions, and incubated at room temperature for 15 min before flow cytometry analysis according to 
the manufacturer’s instructions. All samples were prepared and measured in triplicate, with n = 3 independent 
experiments performed.
Fluorescence detection and recording was assessed by flow cytometry (BD LSRFortessa (BD Bioscience)) with 
the background fluorescence control estimated from using untransfected cells and negative controls determined 
by the GFP-only cells (GFP, Green channel) and SYTOX-only cells (SYTOX, Red channel). The voltage applied 
to each channel was adjusted according to the GFP-only or SYTOX-only controls to avoid the fluorescence count 
exceeding 100 K. For analysis, 50,000–75,000 cells were recorded by the cytometer for each sample. FlowJo soft-
ware (Version vX.0.7) was used in the analysis. The gating of debris and intact Neuro-2a cells was based on 
forward scatter-height (FSC-H) and the dead cell stain (APC-A). Further gating of single cells was based on the 
side scatter-height (SSC-H) and side scatter-width (SSC-W) or FSC-H and forward scatter-width (FSC-W). The 
gating for transfected cells was based on fluorescence GFP-A (GFP, Green channel); the gate for dead cells was 
based on fluorescence APC-A (SYTOX, Red channel). Cell death percentage (%) in each fluorescence range was 
determined using the following formula: Number of 100 × (dead cells/number of total cells).
Statistical analysis. Graphpad Prism 6 (version 6.00 for Mac) was used for statistical analysis. Data are rep-
resented as mean ± standard error of the mean (SEM). Data sets were analyzed by D’Agostino-Pearson omnibus 
normality test before further comparison analysis. For datasets with normal distribution, an unpaired two-tailed 
Figure 10. Model showing the multiple factors contributing to the tunable dynamics of ataxin-1 NBs. Ataxin-1 
can transit through three stages: diffuse nuclear protein, liquid droplet and then hydrogel, with multiple factors 
controlling these transitions. Initially, perturbations in ataxin-1 protein level or RNA/transcription, or by 
1,6-hexanediol, can influence the transition from diffuse protein to dynamic liquid droplets that are visualized 
as distinct spherical ataxin-1 NB; fusion can result in larger NBs, but additional factors of time, altered RNA 
helicases by inhibitor RK-33 or siRNA, ATP depletion, or environmental stresses impact these ataxin-1 NBs to 
establish a less exchange dynamic and molecular fluctuation hydrogel state.
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student’s t-test (for 2 data sets) or analysis by ANOVA (for > 2 data sets) was applied to compare differences 
among different datasets, followed by Tukey’s multiple comparisons test; *p < 0.05, **p < 0.01, ***p < 0.001, 
****p < 0.0001. For datasets with deviation from normal distribution, Mann-Whitney and Kruskal-Wallis 
non-parametric test was used for analysis; #p < 0.05, ##p < 0.01, ###p < 0.001, ####p < 0.0001.
Data availability
Materials used and data analysed during the current study are available from the corresponding authors on 
reasonable request.
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